Genome Editing/Genome Engineering Market Report
RA01783
Genome Editing/Genome Engineering Market, by Product Services (Reagents & Consumables, Software & Systems, Services), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Other Applications), End Use (Pharmaceutical Companies, Biotechnology Companies, Academic & Government Research Institutes), Technique (CRISPR, TALEN, ZFN, Antisense, Other Technologies): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global genome editing/genome engineering market is estimated to surpass $15,306.3 million by 2027, exhibiting a CAGR of 17.0% from 2020 to 2027.
OFFERINGS OF THE REPORT:
The report offers comprehensive analysis of the global genome editing/genome engineering market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market.
The report also sheds light on present scenario and upcoming trends and developments that are contributing in the growth of the market. In addition, key market boomers and opportunities driving the market growth are provided in the report. Besides, restraints and challenges that hold power to obstruct the market growth are also profiled in the report. The report also offers Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.
Based on the key forces molding the market, the report offers future perspective and growth outlook of the global market. The report offers market size and forecast by keenly evaluating every segment of the global genome editing/genome engineering market. Regional market breakdown of these segments is also offered in the report. The report divides the global genome editing/genome engineering market into four main regions including Europe, North America, Asia-Pacific, and LAMEA. Furthermore, these regions are sub-divided to profile detailed panorama of the genome editing/genome engineering market across major countries in specific regions. Moreover, the report reveals some of the recent developments, trends, and forthcoming opportunities in every region.
HIGHLIGHTS OF THE MARKET
- The report offers market size and forecast for the period from 2019 to 2027
- This report highlights trends, innovations, and new developments along with a detailed quantitative analysis of the genome editing/genome engineering market during the period of forecast
- The prevailing and upcoming opportunities along with the tactical assessment of the global genome editing/genome engineering market growth is provided
- The market size and estimations are based on a comprehensive analysis of market drivers and restraints and key innovations in the genome editing/genome engineering market
- Information on leading market players, Porter’s Five Analysis, and top winning business strategies is offered
- The development plans and initiatives undertaken by the top market players are highlighted to understand the competitive landscape of the market
KEY MARKET SEGMENTS
The report segments the global market into product services ,application ,end use ,technique
- Product Services: Reagents & Consumables, Software & Systems, Services
- Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Other Applications
- End Use: Pharmaceutical Companies, Biotechnology Companies, Academic & Government Research Institutes
- Technique: CRISPR, TALEN, ZFN, Antisense, Other Technologies
Region:
The global genome editing/genome engineering market is divided into North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further dived in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
LEADING PLAYERS OF THE MARKET
The most influential companies are mentioned in the report which include Eurofins Scientific, Lonza, Thermo Fisher Scientific, Lonza
The report outlines the business overview including financial performance, latest strategic moves & developments, product portfolio, and SWOT analysis of the leading players of the genome editing/genome engineering market.
1. Thermo Fisher Scientific
2. Merck
3. Horizon Discovery Limited
4. Lonza
5. GenScript
6. Eurofins Scientific
7. Sangamo Therapeutics
8. Editas Medicine
9. CRISPR Therapeutics
10. Precision Biosciences
RESEARCH METHODOLOGY
The report is formulated by in-house market analysts by deeply scrutinizing the market scenario. The market predictions stated in the report have been derived using proven research methodologies and analytical tools & models. Use of such advanced and effective tools, helps market analysts in scrutinizing, filtering, and offering highly accurate data and predictions. The report delivers an extensive research and analysis backed with a variety of factual data, which mainly include interviews with industry players, trustworthy and renowned sources of statistics, and regional intelligence. The insights provided in the report can help investors in understanding investment suitability and market players to grab opportunities for investments, partnerships, and developments in the global market.
The research report is formed by collating different statistics and information concerning the genome editing/genome engineering market. For instance, around 18 hours of interviews and deliberations have been performed with a group of stakeholders and investors, including upstream and downstream members. Primary research is the main part of the research efforts; however, it is reasonably supported by all-encompassing secondary research. About 5,900 product type literatures, market publications, company annual reports, and other such relevant documents of key market players have been studied, for better understanding of market penetration. Furthermore, trustworthy industry newsletters, medical journals, trade associations’ publications, and government websites have also been evaluated for extracting vital industry insights.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Genome Editing/Genome Engineering Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Genome Editing/Genome Engineering Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Genome Editing/Genome Engineering Market, By End Use
5.1. Overview
5.2 Reagents & Consumables
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Software & Systems
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Services
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Genome Editing/Genome Engineering Market, By Technology
6.1. Overview
6.2 Cell Line Engineering
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Genetic Engineering
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Diagnostic Applications
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Drug Discovery & Development
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Other Applications
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Research Dive Exclusive Insights
6.7.1 Market attractiveness
6.7.2 Competition heatmap
-
7. Genome Editing/Genome Engineering Market, By Distribution Channel
7.1. Overview
7.2 Pharmaceutical Companies
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Biotechnology Companies
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Academic & Government Research Institutes
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Research Dive Exclusive Insights
7.5.1 Market attractiveness
7.5.2 Competition heatmap
-
8. Genome Editing/Genome Engineering Market, By Disease Type
8.1. Overview
8.2 CRISPR
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 TALEN
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 ZFN
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Antisense
8.5.1 Definition, key trends, growth factors, and opportunities
8.5.2 Market size analysis, by region, 2020-2027
8.5.3 Market share analysis, by country, 2020-2027
8.6 Other Technologies
8.6.1 Definition, key trends, growth factors, and opportunities
8.6.2 Market size analysis, by region, 2020-2027
8.6.3 Market share analysis, by country, 2020-2027
8.7 Research Dive Exclusive Insights
8.7.1 Market attractiveness
8.7.2 Competition heatmap
9. Genome Editing/Genome Engineering Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By End Use, 2020-2027
9.1.1.2 Market size analysis, By Technology, 2020-2027
9.1.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.1.1.4 Market size analysis, By Disease Type, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By End Use, 2020-2027
9.1.2.2 Market size analysis, By Technology, 2020-2027
9.1.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.1.2.4 Market size analysis, By Disease Type, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By End Use, 2020-2027
9.1.3.2 Market size analysis, By Technology, 2020-2027
9.1.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.1.3.4 Market size analysis, By Disease Type, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By End Use, 2020-2027
9.2.1.2 Market size analysis, By Technology, 2020-2027
9.2.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.1.4 Market size analysis, By Disease Type, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By End Use, 2020-2027
9.2.2.2 Market size analysis, By Technology, 2020-2027
9.2.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.2.4 Market size analysis, By Disease Type, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By End Use, 2020-2027
9.2.3.2 Market size analysis, By Technology, 2020-2027
9.2.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.3.4 Market size analysis, By Disease Type, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By End Use, 2020-2027
9.2.4.2 Market size analysis, By Technology, 2020-2027
9.2.4.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.4.4 Market size analysis, By Disease Type, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By End Use, 2020-2027
9.2.5.2 Market size analysis, By Technology, 2020-2027
9.2.5.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.5.4 Market size analysis, By Disease Type, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By End Use, 2020-2027
9.2.6.2 Market size analysis, By Technology, 2020-2027
9.2.6.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.6.4 Market size analysis, By Disease Type, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By End Use, 2020-2027
9.3.1.2 Market size analysis, By Technology, 2020-2027
9.3.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.1.4 Market size analysis, By Disease Type, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By End Use, 2020-2027
9.3.2.2 Market size analysis, By Technology, 2020-2027
9.3.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.2.4 Market size analysis, By Disease Type, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By End Use, 2020-2027
9.3.3.2 Market size analysis, By Technology, 2020-2027
9.3.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.3.4 Market size analysis, By Disease Type, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By End Use, 2020-2027
9.3.4.2 Market size analysis, By Technology, 2020-2027
9.3.4.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.4.4 Market size analysis, By Disease Type, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By End Use, 2020-2027
9.3.5.2 Market size analysis, By Technology, 2020-2027
9.3.5.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.5.4 Market size analysis, By Disease Type, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By End Use, 2020-2027
9.3.6.2 Market size analysis, By Technology, 2020-2027
9.3.6.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.6.4 Market size analysis, By Disease Type, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By End Use, 2020-2027
9.4.1.2 Market size analysis, By Technology, 2020-2027
9.4.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.1.4 Market size analysis, By Disease Type, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By End Use, 2020-2027
9.4.2.2 Market size analysis, By Technology, 2020-2027
9.4.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.2.4 Market size analysis, By Disease Type, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By End Use, 2020-2027
9.4.3.2 Market size analysis, By Technology, 2020-2027
9.4.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.3.4 Market size analysis, By Disease Type, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By End Use, 2020-2027
9.4.4.2 Market size analysis, By Technology, 2020-2027
9.4.4.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.4.4 Market size analysis, By Disease Type, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By End Use, 2020-2027
9.4.5.2 Market size analysis, By Technology, 2020-2027
9.4.5.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.5.4 Market size analysis, By Disease Type, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 Merck
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 Horizon Discovery Limited
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 Lonza
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 GenScript
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Eurofins Scientific
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 Sangamo Therapeutics
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Editas Medicine
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 CRISPR Therapeutics
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 Precision Biosciences
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
